StockNews.com initiated coverage on shares of 2U (NASDAQ:TWOU – Free Report) in a report published on Tuesday. The firm issued a hold rating on the software maker’s stock.
Separately, Needham & Company LLC restated a hold rating on shares of 2U in a research report on Friday, July 26th. Seven research analysts have rated the stock with a hold rating, According to data from MarketBeat, the company currently has an average rating of Hold and a consensus target price of $54.00.
View Our Latest Analysis on TWOU
2U Stock Performance
Institutional Investors Weigh In On 2U
Several institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets raised its stake in shares of 2U by 49.0% in the 4th quarter. BNP Paribas Financial Markets now owns 1,331,482 shares of the software maker’s stock valued at $1,638,000 after purchasing an additional 438,007 shares during the period. Price T Rowe Associates Inc. MD raised its position in 2U by 232.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 361,725 shares of the software maker’s stock valued at $141,000 after buying an additional 252,800 shares during the last quarter. Keynote Financial Services LLC acquired a new stake in 2U in the 1st quarter valued at approximately $69,000. Finally, Los Angeles Capital Management LLC lifted its stake in 2U by 76.1% in the 1st quarter. Los Angeles Capital Management LLC now owns 627,394 shares of the software maker’s stock valued at $244,000 after acquiring an additional 271,133 shares in the last quarter. 80.53% of the stock is owned by institutional investors.
2U Company Profile
2U, Inc operates as an online education platform company in the United States and internationally. The company operates through two segments, Degree Program and Alternative Credential. The Degree Program segment provides the technology and services to nonprofit colleges and universities to enable the online delivery of degree programs.
Further Reading
- Five stocks we like better than 2U
- Using the MarketBeat Dividend Yield Calculator
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- The Risks of Owning Bonds
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- ETF Screener: Uses and Step-by-Step Guide
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for 2U Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 2U and related companies with MarketBeat.com's FREE daily email newsletter.